Live feed
Filing
SC 13D/A
SC 13D/A0001104659-24-041995·Apogee Therapeutics, Inc.
Schedule 13D ownership disclosure
Apogee Therapeutics Inc
Security class unavailable · CUSIP: 03770N101
Event date: 2024-03-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,762,558
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-041995
- Form type
- SC 13D/A
- Filer
- Apogee Therapeutics, Inc.
- CIK
- CIK 1974640
- Filed
- Apr 01, 2024
- Reporting period
- Mar 28, 2024
- Description
- Schedule 13D beneficial ownership